Mind + Muscle

technical minds + legal muscle


dig deep

Jorge Goldstein Discusses the Implications of the Myriad Case

  • 05.06.10
  • Sterne, Kessler, Goldstein & Fox P.L.L.C.

A federal  District Court  in New York recently ruled, in Association for Molecular Pathology et al. v. U.S. Patent and Trademark Office et al. that isolated human genes are not patentable subject matter.  While this case (commonly referred to as the Myriad case) challenges the availability of patents on isolated genes and their fragments, its reasoning, if upheld on appeal, could be extended to invalidate patents on other natural products, such as natural antibiotics, natural proteins, etc.  In this short video, Dr. Jorge Goldstein provides a brief update on the scope of the case and its potential impact.  To view the video, click here.

Related People

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.